Logo Image
News|Articles|February 14, 2018

Apace Packaging Recalls Acyclovir

The company is voluntarily recalling one lot of Acyclovir Tablet due to packaging that may contain a different product.

Apace Packaging LLC announced on Feb. 13, 2018 that it was voluntarily recalling one lot of Acyclovir Tablet, USP, 400mg, 50ct Unit Dose to the retail level because some packages may contain Torsemide, 20mg tablets. The affected lot, number 19900, has an expiration date of May 2019 and was distributed to R&S Northeast and nationwide.

The company has not yet received any reports of adverse events associated with the recalled product; however, it says that missing a dose of Acyclovir may cause reactivation of the virus being treated. In additional, unintentional use of Torsemide could cause excessive urination.

Acyclovir is used for the treatment of herpes zoster (shingles), genital herpes, and chickenpox. Torsemide is used to treat edema and hypertension.

Source: FDA

Related to this article

View more
Regulatory Roundup—September 2026
Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Read more
Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
CPHI Milan 2026: Digital Supply Chains
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
Read more